Cargando…

SAT-498 Use of Cinacalcet for PTHrP-Mediated Hypercalcemia of Malignancy in Penile Squamous Cell Carcinoma

Background: PTHrP-mediated hypercalcemia accounts for 80% of hypercalcemia of malignancy (HCM), and is traditionally treated with bisphosphonates or hemodialysis. We report a patient with penile squamous cell carcinoma (SCC) and bisphosphonate resistant PTHrP-mediated HCM that responded to calcimime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pulipati, Vishnu Priya, Ganesh, Malini, Baim, Sanford
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552553/ http://dx.doi.org/10.1210/js.2019-SAT-498

Ejemplares similares

SAT-LB63 A Case of PTHrP-Negative Hypercalcemia of Malignancy
por: Murati, Jonila, et al.
Publicado: (2020)

SAT-493 A Case of Endometrial Adenocarcinoma Presenting with PTHrP-Mediated Hypercalcemia
por: Weaver, Anne, et al.
Publicado: (2019)

SAT-346 Hypercalcemia Secondary to Calcitriol and PTHrP Cosecretion Only Responsive to Hydroxychloroquine
por: Panvelker, Samir S, et al.
Publicado: (2020)

Prednisone-Responsive Hypercalcemia in a Patient With IgG4 Disease and Elevated Serum PTHrP Levels
por: Cohen, Melissa, et al.
Publicado: (2021)

PSAT208 A Case of Hypercalcemia From PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy
por: Niu, Isabella, et al.
Publicado: (2022)

SAT253 A Rare Case Of Osteolytic Hypercalcemia Of Malignancy In Acute Myeloid Leukemia
por: Elahi, Safiya, et al.
Publicado: (2023)

Extreme Secretion of PTHrP From a Pancreatic Neuroendocrine Tumor, A Shift From Severe Hypercalcemia to Hypocalcemia
por: Nachawi, Noura, et al.
Publicado: (2021)

SAT-LB70 Relationship Between LC-MS/MS Measurements of PTHrP and Calcium in Patients With Compromised Renal Function
por: Kroner, Grace, et al.
Publicado: (2020)

SUN-509 A Challenging Case of Symptomatic Primary Hyperparathyroidism during Pregnancy Treated with Cinacalcet
por: Rodriguez, Aleida, et al.
Publicado: (2019)

MON-343 The Mystery of Recurrent PTH-Independent Hypercalcemia with Severe Hypophosphatemia
por: Shaikh, Bilal, et al.
Publicado: (2020)

Clinical Risk Factors for Osteoporotic Fractures in Men With Non-Metastatic Prostate Cancer on Androgen Deprivation Therapy With or Without Anti-Osteoporosis Treatment
por: Sonnabend, Hajerah, et al.
Publicado: (2021)

SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023)

SUN-508 Intravenous Bisphosphonates Induced Renal Injury with Nephrotic Range Proteinuria in a Patient with Severe Hypercalcemia Secondary to Parathyroid Carcinoma
por: Gorantla, Yamuna, et al.
Publicado: (2019)

SUN-LB086 Hypercalcemia in Metastatic Cholangiocarcinoma Due to Coexisting Elevated Parathyroid Hormone Related Protein (PTHrP) and 1,25-Dihydroxy Vitamin D (Calcitriol): A Case Report
por: Sharma, Rajeev
Publicado: (2019)

RF30 | PSAT135 Rare Case of Hypercalcemia Mediated by an Ectopic Parathyroid Hormone (PTH), and Parathyroid Hormone-Related Peptide (PTHrP) Co-Secretion Secondary to Metastatic Cervical Carcinoma
por: Gaballa, Salem, et al.
Publicado: (2022)

SAT246 Ectopic (Penile) Calcification in 1, 25 Vitamin D Induced Hypercalcemia
por: Berquist, John, et al.
Publicado: (2023)

FRI693 Pthrp Mediated Hypercalcemia In A Patient With Recurrent Hepatocellular Carcinoma
por: Bondarenko, Darya, et al.
Publicado: (2023)

SAT-402 Investigating Analogues of Parathyroid Hormone (PTH) and PTH-Related Peptide (PTHrP) to Improve Anabolic: Catabolic Response Ratios Using UMR106-01 Osteocytic Cells
por: Oladapo, Oladipo Posi, et al.
Publicado: (2020)

OR21-4 Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome
por: He, Zhiming, et al.
Publicado: (2022)

SAT-153 PTHrP Mediated Hypercalcemia
por: Arguello, Mingxue
Publicado: (2020)

SAT-355 Severe Symptomatic Hypocalcemia Related to Cinacalcet Administration Introduction
por: Weaver, Travis, et al.
Publicado: (2020)

SAT-345 Etanercept Induced Hypercalcemia
por: Chaker, Bayan, et al.
Publicado: (2020)

SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

SAT-497 Importance of OTC Medications in Hypercalcemia
por: Yedla, Niharika, et al.
Publicado: (2019)

SAT-366 Hypercalcemia Due to Castleman’s Disease
por: Khan, Sarah Adil, et al.
Publicado: (2020)

SAT-359 Hypercalcemia - Is This Sarcoidosis, Hyperparathyroidism, or Both?
por: Veeramachaneni, Ravali, et al.
Publicado: (2020)

SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019)

SAT256 Buschke Loewenstein Tumor Presenting With Hypercalcemia
por: Jones, Kai, et al.
Publicado: (2023)

SAT244 Hypercalcemia Induced By Inconspicuous Histoplasmosis Infection
por: Alkhathlan, Mujahed, et al.
Publicado: (2023)

SAT241 Severe Hypercalcemia Secondary To Likely Sarcoidosis
por: Nair, Nirmal
Publicado: (2023)

OR30-5 Germline Ablation of G-Protein Subunit Alpha-11 in Mice Causes Hypercalcemia That Is Rectified by Treatment with Cinacalcet
por: Hannan, Fadil, et al.
Publicado: (2019)

SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
por: Dbeis, Ammer, et al.
Publicado: (2019)

SAT260 Asymptomatic Vitamin A Toxicity Causing Hypercalcemia
por: Seshan, Nandini, et al.
Publicado: (2023)

SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
por: Sistla, Divya, et al.
Publicado: (2019)

SAT-501 A Rare and Potentially Fatal Etiology of Hypercalcemia in an Infant
por: Sonawalla, Ambreen, et al.
Publicado: (2019)

SAT251 A Tale Of Two Calcium Disorders: Hypercalcemia In Pregnancy
por: Stezzi, Marc, et al.
Publicado: (2023)

LBSAT142 Discovery And Characterization Of A Potent And Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist For The Treatment Of Hypercalcemia
por: Rico-Bautista, Elizabeth, et al.
Publicado: (2022)

SAT-510 Hypercalcemia Secondary to Vitamin D Intoxication and Nephrocalcinosis in 2 Children
por: Diaz, Alejandro, et al.
Publicado: (2019)

SAT-496 Symptomatic Hypercalcemia in a Transgender Patient with Silicone-Induced Granulomas
por: Ghazzawi, Ziad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bbkrkbb2quj1tg6oicipn474g2